Human melanoma cells with high susceptibility to cell‐mediated lysis can be identified on the basis of icam‐1 phenotype, vla profile and invasive ability
暂无分享,去创建一个
[1] A. Anichini,et al. Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy? , 1990, Journal of the National Cancer Institute.
[2] M. Elices,et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.
[3] A. Anichini,et al. Cytokine‐mediated modulation of HLA‐class II, ICAM‐1, LFA‐3 and tumor‐associated antigen profile of melanoma cells. comparison with anti‐proliferative activity by RIL1‐β, RTNF‐α, RIFN‐γ, RIl4 and their combinations , 1990 .
[4] W. Carter,et al. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin , 1989, The Journal of cell biology.
[5] G. Freeman,et al. Isolated human follicular dendritic cells display a unique antigenic phenotype , 1989, The Journal of experimental medicine.
[6] R. Testi,et al. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule , 1989, The Journal of experimental medicine.
[7] A. Anichini,et al. Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. , 1989, Journal of immunology.
[8] M. Elices,et al. The primary structure of the alpha 4 subunit of VLA‐4: homology to other integrins and a possible cell‐cell adhesion function. , 1989, The EMBO journal.
[9] W. Carter,et al. The membrane glycoprotein Ia-IIa (VLA-2) complex mediates the Mg++- dependent adhesion of platelets to collagen , 1989, The Journal of cell biology.
[10] A. Sonnenberg,et al. Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA beta 1 subunit on certain cell lines. , 1989, The Journal of biological chemistry.
[11] Jeffrey W. Smith,et al. A novel vitronectin receptor integrin (α v β x ) is responsible for distinct adhesive properties of carcinoma cells , 1989, Cell.
[12] J. A. Mourik,et al. Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex , 1989 .
[13] V. Quaranta,et al. A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. , 1989, The EMBO journal.
[14] R. Kramer,et al. Melanoma cell adhesion to basement membrane mediated by integrin-related complexes. , 1989, Cancer research.
[15] I. Weissman,et al. Identification of a murine Peyer's patch—specific lymphocyte homing receptor as an integrin molecule with an α chain homologous to human VLA-4α , 1989, Cell.
[16] B. Bierer,et al. T cell adhesion molecules , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] A. Sonnenberg,et al. Multiple very late antigen (VLA) heterodimers on platelets. Evidence for distinct VLA-2, VLA-5 (fibronectin receptor), and VLA-6 structures. , 1988, The Journal of biological chemistry.
[18] T. Springer,et al. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells , 1988, Nature.
[19] S. Rosenberg. Immunotherapy of cancer using interleukin 2: current status and future prospects. , 1988, Immunology today.
[20] D. Cheresh,et al. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. , 1987, The Journal of biological chemistry.
[21] E Ruoslahti,et al. New perspectives in cell adhesion: RGD and integrins. , 1987, Science.
[22] J. Strominger,et al. Characterization of the cell surface heterodimer VLA-4 and related peptides. , 1987, The Journal of biological chemistry.
[23] Y Iwamoto,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.
[24] M. Hemler,et al. The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta subunit. , 1987, The Journal of biological chemistry.
[25] D. Cheresh,et al. Human tumor antigens. , 1987, Advances in immunology.
[26] A. Anichini,et al. Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon γ , 1986, International journal of cancer.
[27] L. Lanier,et al. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis , 1986, The Journal of experimental medicine.
[28] A. Anichini,et al. Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones , 1986, The Journal of experimental medicine.
[29] L. Liotta,et al. Biochemical interactions of tumor cells with the basement membrane. , 1986, Annual review of biochemistry.
[30] M. Horton,et al. Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. , 1985, Cancer research.
[31] V. Schirrmacher. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. , 1985, Advances in cancer research.
[32] Liotta La. Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. , 1984 .
[33] N. Hogg,et al. Monoclonal antibodies specific for platelet glycoproteins react with human monocytes. , 1984, Blood.
[34] T. Flotte,et al. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. , 1984, Journal of immunology.
[35] P. Lansdorp,et al. Monoclonal antibodies against human platelet glycoprotein IIIa , 1983, British journal of haematology.
[36] J. Strominger,et al. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Moore,et al. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours , 1979, International journal of cancer.